Financhill
Sell
50

PBYI Quote, Financials, Valuation and Earnings

Last price:
$5.96
Seasonality move :
11.22%
Day range:
$5.72 - $5.99
52-week range:
$2.58 - $6.12
Dividend yield:
0%
P/E ratio:
7.98x
P/S ratio:
1.40x
P/B ratio:
2.58x
Volume:
405.5K
Avg. volume:
449.2K
1-year change:
110.32%
Market cap:
$297.8M
Revenue:
$230.5M
EPS (TTM):
$0.74

Earnings Data

Next earnings date for PBYI
Mar 05
2026
Most recent earnings per share
$0.17
Beat by $0.08
(Nov 6/2025)
Consensus Estimate
$0.09
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PBYI Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/05/2026 Q4 $68.6M -- -- $0.23 --
11/06/2025 Q3 $51M $54.5M $0.17 $0.09 $0.08
08/07/2025 Q2 $52M $52.4M $0.12 $0.07 $0.05
05/08/2025 Q1 $44.6M $46M $0.06 $0.03 $0.03
02/27/2025 Q4 $52.5M $59.1M $0.39 $0.14 $0.25
11/07/2024 Q3 $70.7M $80.5M $0.41 $0.38 $0.03
08/01/2024 Q2 $44.7M $47.1M -$0.09 -$0.11 $0.01
05/02/2024 Q1 $49.1M $43.8M -$0.10 -$0.16 $0.06
02/29/2024 Q4 $73.6M $72.2M $0.26 $0.37 -$0.11
11/02/2023 Q3 $58M $56.1M $0.12 $0.14 -$0.02
08/03/2023 Q2 -- $54.6M $0.05 -- --
05/04/2023 Q1 -- $52.8M $0.03 -- --
03/02/2023 Q4 -- $65.7M -$0.12 -- --
11/03/2022 Q3 -- $57.1M -$0.01 -- --
08/04/2022 Q2 -- $59.5M $0.21 -- --
05/05/2022 Q1 -- $45.7M -$0.08 -- --
03/03/2022 Q4 -- $55.4M $0.10 -- --
11/04/2021 Q3 -- $46.2M -$1.09 -- --
08/05/2021 Q2 -- $53.4M -$0.13 -- --
05/06/2021 Q1 -- $98.2M $0.40 -- --
02/25/2021 Q4 -- $52.6M -$0.38 -- --
11/05/2020 Q3 -- $50.8M -$0.79 -- --
08/06/2020 Q2 -- $70.6M $0.08 -- --
05/07/2020 Q1 -- $51.2M -$0.43 -- --
02/20/2020 Q4 -- $62.9M -$0.29 -- --
11/06/2019 Q3 -- $56.4M -$0.43 -- --
08/08/2019 Q2 -- $53.9M -$0.97 -- --
05/09/2019 Q1 -- $99.1M -$0.26 -- --
02/28/2019 Q4 -- $71.1M -$0.80 -- --
11/01/2018 Q3 -- $62.6M -$0.37 -- --
08/09/2018 Q2 -- $50.8M -$1.17 -- --
05/09/2018 Q1 -- $66.5M -$0.65 -- --
03/01/2018 Q4 -- $21.6M -$1.71 -- --
11/09/2017 Q3 -- $6.1M -$2.07 -- --
08/09/2017 Q2 -- -- -$2.10 -- --
05/10/2017 Q1 -- -- -$1.97 -- --
03/01/2017 Q4 -- -- -$2.04 -- --
11/09/2016 Q3 -- -- -$2.02 -- --
08/09/2016 Q2 -- -- -$2.05 -- --
05/09/2016 Q1 -- -- -$2.19 -- --
03/07/2016 Q4 -- -- -$1.90 -- --

Puma Biotechnology, Inc. Earnings Questions

  • How Much did Puma Biotechnology, Inc. Generate in Revenue Last Quarter?

    Puma Biotechnology, Inc. reported $54.5M worth of top line sales in its most recent quarter.

  • Did Puma Biotechnology, Inc. Beat Earnings Last Quarter?

    Puma Biotechnology, Inc. announced earnings per share of $0.17 which represents a beat of analyst forecast a $0.09 per share.

  • Is Puma Biotechnology, Inc. Profitable?

    Puma Biotechnology, Inc. reported $42.3M that represents $0.83 per share over the last quarter.

  • What is the Analyst Consensus for Puma Biotechnology, Inc. EPS Next Year?

    Puma Biotechnology, Inc.'s earnings are forecast to grow from $0.62 per share to $0.50 per share next year representing an increase of 11.9%.

  • When is Puma Biotechnology, Inc.'s Earnings Date?

    Puma Biotechnology, Inc.'s next earnings date is March 5, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock